Oncology Learning Network
Hospitals and Health Care
East Windsor, New Jersey 911 followers
Oncology education that improves patient care.
About us
Oncology Learning Network® is an online resource for the latest developments in oncology practice, providing a customized experience for readers to stay informed about the topics that matter most to them. Through clinical insights, peer-reviewed journal articles, interactive features, research news updates, accredited continuing educational programs, and professional live meetings and events, Oncology Learning Network serves as a collaborative learning and networking environment for a multidisciplinary community of oncology medical professionals. As the digital home to the respected Journal of Clinical Pathways—a peer-reviewed journal featuring original research, insights, and perspectives on clinical pathways and other value-based approaches in health care —as well as the well-known online and live continuing education programs in oncology provided by Imedex and NACCME, Oncology Learning Network allows busy oncology providers to meet all of their educational and informational needs in one place.
- Website
-
http://www.oncnet.com
External link for Oncology Learning Network
- Industry
- Hospitals and Health Care
- Company size
- 1 employee
- Headquarters
- East Windsor, New Jersey
- Type
- Privately Held
Locations
-
Primary
104 Windsor Center Dr
Suite 200
East Windsor, New Jersey 08520, US
Updates
-
According to Pierre Wolkenstein, MD, PhD, Henri Mondor Hospital, and coauthors, "These data emphasize the need for effective treatments that target PN progression and improve the burden of disease." Learn more: https://lnkd.in/e3SrDGAX
-
-
Findings from a phase 2 study show treatment with selumetinib led to significant shrinkage of plexiform neurofibromas among pediatric patients with neurofibromas type 1. Learn more: https://lnkd.in/e2Mxd6x4
-
-
As Martin Schuler, MD, University Hospital Essen, concluded, “erdafitinib demonstrated clinically meaningful activity in this rare lung cancer entity in heavily pretreated patients with non-small cell lung cancer harboring pre-specified FGFR alterations…and responses were observed in fusions and mutations and in squamous and non-squamous histologies.” Learn more: https://lnkd.in/eTkjY8DU
-
-
According to Carolina Robert, MD, Gustave Roussy, "data supports the hypothesis that patients with very high LDH (>2ULN) and those with liver metastases benefit from the sequential approach in terms of PFS." Learn more: https://lnkd.in/eNmputTu
-
-
Oncology Learning Network reposted this
📸 #MondayMemories: Our inaugural events of the season were a tremendous success. Check out some of our favorite moments captured on-site. Don’t miss out on our second round of events—register now at greatdebatesandupdates.com 📅 #GDUHEM: July 27-28 | Los Angeles; #GDULC: October 5-6 | Dallas; #GDUGI: October 19-20 | Dallas; #GDUWO: November 1-2 | Nashville #greatdebatesandupdates #gdu #oncologycme
-
-
Oncology Learning Network reposted this
📅 Clinicians, mark your calendars. #GDUHEM is headed to a new city. Dive into cutting-edge advancements, network with industry leaders, and gain invaluable insights to elevate your practice. Don't miss out on this opportunity to be at the forefront of innovation. July 27-28 | Los Angeles ➡ hmpglobalevents.com/gduhem
-
According to Vijay Maruti Patil, MD, MBBS, P.D. Hinduja Sindhi Hospital, "The addition of low-dose nivolumab to triple metronomic chemotherapy leads to a tripling of OS thus suggesting that even low-dose nivolumab has sustainable benefits." Learn more: https://lnkd.in/ed8BbHbB
-
-
The FDA approved the new drug application for SH-105, a liquid, ready-to-dilute form of thiotepa, for the treatment of patients with breast and ovarian cancer. Learn more: https://lnkd.in/exzigBen
-
-
According to James Chih-Hsin Yang, MD, PhD, National Taiwan University, this study “achieved its primary objective, with manageable safety profile in platinum-based chemotherapy pretreated NSCLC with EGFR exon20ins.” Learn more: https://lnkd.in/eePezGb8
-